Dallas, TX, United States of America

Amit G Singal

This inventor holds 1 USPTO granted patent. Top assignees: Hôpitaux Universitaires De Strasbourg (Hus), National Institute of Health and Medical Research, The University of Texas System. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Liver Disease Assessment by Amit G Singal

Introduction

Amit G Singal is a prominent inventor based in Dallas, TX (US), known for his significant contributions to the field of liver disease research. His work focuses on developing methods for assessing risk and treatments for liver cancers and lethal liver disease complications. With a commitment to improving patient outcomes, Singal has made strides in the early diagnosis and prevention of hepatocellular carcinoma (HCC) and other severe complications associated with liver diseases.

Latest Patents

Singal holds a patent titled "Methods for the assessment of risk and treatments for liver cancers and lethal liver disease complications." This patent encompasses methods and compositions designed to predict high- and low-risk liver disease in patients. The innovations disclosed in this patent enable the classification of liver disease patients into prognostic risk groups, which is crucial for early diagnosis and intervention. The methods and compositions significantly enhance the prognosis for individuals at risk for liver diseases, thereby improving their chances of survival.

Career Highlights

Throughout his career, Amit G Singal has worked with esteemed institutions, including the University of Texas System and Université de Strasbourg. His dedication to research and innovation has positioned him as a leading figure in the field of liver disease assessment. Singal's work has not only contributed to academic knowledge but has also had a practical impact on patient care.

Collaborations

Singal has collaborated with notable professionals in his field, including Yujin Hoshida and Naoto Fujiwara. These collaborations have further enriched his research and have led to advancements in understanding liver diseases and their treatment.

Conclusion

Amit G Singal's innovative approaches to liver disease assessment and treatment exemplify the importance of research in improving patient outcomes. His contributions through patents and collaborations continue to pave the way for advancements in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…